RAD51C and ovarian cancer: The cumulative risk of having ovarian cancer by age 80 was estimated to be 11% (95% CI 6–21%) for RAD51C and 13% (95% CI 7–23%) for RAD51D based on their segregation analysis [10] (Table 3).